Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kordasti, S
Right arrow Articles by Svensson, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kordasti, S
Right arrow Articles by Svensson, L
Topic Collections
Right arrowRelevant Article
Gut 2004;53:952-957
© 2004 by BMJ Publishing Group Ltd & British Society of Gastroenterology


SMALL INTESTINE

Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea

S Kordasti1, H Sjövall2, O Lundgren2, L Svensson3

1 Department of Virology, Swedish Institute for infectious Disease Control, 172 82 Solna, Sweden, and Department of Physiology, Box 432, S-405 30 Göteborg University, Göteborg, Sweden
2 Department of Physiology, Box 432, S-405 30 Göteborg University, Göteborg, Sweden
3 Department of Virology, Swedish Institute for Infectious Disease Control, 172 82 Solna, Sweden, and Department of Molecular and Clinical Medicine, University of Linköping, Linköping, Sweden

Correspondence to:
Correspondence to:
Dr S Kordasti
Department of Molecular and Clinical Medicine, University of Linköping, 581 85 Linköping, Sweden; shirin.kordasti{at}nll.se

Background and aims: The mechanisms underlying intestinal secretion in rotavirus diarrhoea remain to be established. We previously reported that rotavirus evokes intestinal fluid and electrolyte secretion by activation of the enteric nervous system. We now report that antagonists for the 5-hydroxytryptamine 3 receptor (5-HT3) and vasoactive intestinal peptide (VIP) receptor, but not antagonists for 5-hydroxytryptamine 4 receptor or the muscarinic receptor, attenuate rotavirus induced diarrhoea.

Methods: Neurotransmitter antagonists were administered to wild-type or neurokinin 1 receptor knockout mice infected with homologous (EDIM) or heterologous (RRV) rotavirus.

Results: While RRV infected mice had diarrhoea for 3.3 (0.2) days (95% confidence interval (CI) 3.04–3.56), the 5-HT3 receptor antagonist (granisetron) and the VIP receptor antagonist (4Cl-D-Phe6,Leu17)-VIP both reduced the total number of days of RRV induced diarrhoea to 2.1 (0.3) (95% CI 1.31–2.9) (p<0.01). EDIM infected mice treated with granisetron had a significantly shorter duration of diarrhoea (5.6 (0.4) days) compared with untreated mice (8.0 (0.4) days; p<0.01). Experiments with neurokinin 1 receptor antagonists suggest that this receptor may possibly be involved in the secretory response to rotavirus. On the other hand, rotavirus diarrhoea was not attenuated in the neurokinin 1 receptor knockout mice.

Conclusions: Our results suggest that the neurotransmitters serotonin and VIP are involved in rotavirus diarrhoea; observations that could imply new principles for treatment of this disease with significant global impact.


Abbreviations: CT, cholera toxin; ENS, enteric nervous system; NK-1, neurokinin 1; NK-1R–/–, neurokinin 1 receptor knockout mouse; NDD, total number of days with diarrhoea; RRV, rhesus rotavirus; 5-HT3, serotonin 3; SP, substance P; VIP, vasoactive intestinal peptide

Keywords: rotavirus; enteric nervous system; diarrhoea; vasoactive intestinal peptide; serotonin


Relevant Article

Digest
Robin Spiller
Gut 2004 53: 917. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. L Cunningham, E. T Janson, S. Agarwal, L. Grimelius, and M. Stridsberg
Tachykinins in endocrine tumors and the carcinoid syndrome
Eur. J. Endocrinol., September 1, 2008; 159(3): 275 - 282.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Y Motomura, J-E Ghia, H Wang, H Akiho, R T El-Sharkawy, M Collins, Y Wan, J T McLaughlin, and W I Khan
Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments
Gut, April 1, 2008; 57(4): 475 - 481.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H. Wang, J. Steeds, Y. Motomura, Y. Deng, M. Verma-Gandhu, R. T El-Sharkawy, J. T McLaughlin, R. K Grencis, and W. I Khan
CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection
Gut, July 1, 2007; 56(7): 949 - 957.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. Orandle, R. S. Veazey, and A. A. Lackner
Enteric Ganglionitis in Rhesus Macaques Infected with Simian Immunodeficiency Virus
J. Virol., June 15, 2007; 81(12): 6265 - 6275.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Kordasti, C. Istrate, M. Banasaz, M. Rottenberg, H. Sjovall, O. Lundgren, and L. Svensson
Rotavirus Infection Is Not Associated with Small Intestinal Fluid Secretion in the Adult Mouse
J. Virol., November 15, 2006; 80(22): 11355 - 11361.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Kordasti, M. Sapnara, E. A. Thomas, E. Lindstrom, M. Forsman, J. C. Bornstein, and H. Sjovall
Effects of cholera toxin on the potential difference and motor responses induced by distension in the rat proximal small intestine in vivo
Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G948 - G958.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Society of Gastroenterology